MiR23b ameliorates neuropathic pain in spinal cord by silencing NADPH oxidase 4

Antioxidants and Redox Signaling

Volumn 16, Issue 10, 2012, Pages 1046-1060

  Im, Young Bin ^a   Jee, Min Ki ^a   Jung, Jin Sun ^a   Choi, Jee In ^a   Jang, Jin Hwa ^a   Kang, Soo Kyung ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 23B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN BASIC PROTEIN; NESTIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOWN REGULATION; DRUG INFUSION; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; INFLAMMATION; MOUSE; MULTIGENE FAMILY; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD INJURY; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; GENE SILENCING; MICE; MICRORNAS; NADPH OXIDASE; NEURALGIA; SPINAL CORD;

ANIMALIA; MUS;

EID: 84859244635     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4224     Document Type: Article

References (47)

1. Ago T, Kuroda J, Pain J, Fu C, Li H, and Sadoshima J. Up-regulation of Nox4 by hypertrophic stimuli promotes apo-ptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106: 1253-1264, 2010.
2. Aldrich BT, Frakes EP, Kasuya J, Hammond DL, and Kita-moto T. Changes in expression of sensory organ-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve liga-tion. Neuroscience 164: 711-723, 2009.
3. Andrade P, Visser-Vandewalle V, Philippens M, Daemen MA, Steinbusch HW, Buurman WA, and Hoogland G. Tumor necrosis factor-a levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between tumor necrosis factor receptor 1 and 2. Pain 152: 2645-2652, 2011.
4. Arienti C, Daccò S, Piccolo I, and Redaelli T. Osteopathic manipulative treatment is effective on pain control associated to spinal cord injury. Spinal Cord 49: 515-519, 2011.
5. Austin PJ and Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neu-roimmunol 229: 26-50, 2010.
6. Bai G, Ambalavanar R, Wei D, and Dessem D. Down-regulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 3: 15-18, 2007.
7. Boroujerdi A, Zeng J, Sharp K, Kim D, Steward O, and Luo ZD. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 152: 649-655, 2011.
8. Bracken MB. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. J Neurotrauma 8(Suppl 1): S47-S50, 1991.
9. Carlton SM and Hargett GL. Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion cells. J Comp Neurol 501: 780-789, 2007.
10. Colburn RW, Rickman AJ, and DeLeo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157: 289-304, 1999. (Pubitemid 29260737)
11. Dolan S, Gunn MD, Crossan C, and Nolan AM. Activation of metabotropic glutamate receptor 7 in spinal cord inhibits pain and hyperalgesia in a novel formalin model in sheep. Behav Pharmacol 22: 582-588, 2011.
12. Fan S, Li L, Chen S, Yu Y, Qi M, Tashiro SI, Onodera S, and Ikejima T. Silibinin induced-autophagic and apoptotic death is associated with ROS and RNS increase in HeLa cells. Free Radic Res 45: 1307-1324, 2011.
13. Gwak YS and Hulsebosch CE. GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 60: 799-808, 2011.
14. Hama A and Sagen J. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. Brain Res 1412: 44-54, 2011.
15. Hama A and Sagen J. Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J Neurotrauma 28: 127-134, 2011.
16. Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I, Yoles E, Akselrod S, and Schwartz M. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci 23: 8808-8819, 2003. (Pubitemid 37176662)
17. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93: 1-7, 2000.
18. Jiang F, Liu T, Cheng M, Pang XY, Bai ZT, Zhou JJ, and Yi YH. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion buthus martensi karch. Eur J Pharmacol 623: 52-64, 2009.
19. Joo JD, Choi JW, In JH, Jung HS, Lee JA, Kim YS, Kim DW, Yeom JH, Shin EY, and Jeon YS. Lidocaine suppresses the increased extracellular signal-regulated kinase/cyclic AMP response element-binding protein pathway and pro-inflammatory cytokines in a neuropathic pain model of rats. Eur Soc Anaesthesiol 28: 106-111, 2011.
20. Kang SK, Shin MJ, Jung JS, Kim YG, and Kim CH. Auto-logous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells Dev 15: 583-594, 2006. (Pubitemid 44701177)
21. Kielian T, Esen N, Liu S, Phulwani NK, Syed MM, Phillips N, Nishina K, Cheung AL, Schwartzman JD, and Ruhe JJ. Minocycliine modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus-induced brain abscess. Am J Pathol 171: 1199-1214, 2007. (Pubitemid 47582894)
22. Kim D, You B, Jo EK, Han SK, Simon MI, and Lee SJ. NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci USA 107: 14851-14856, 2010.
23. Kumru H, Soler D, Vidal J, Tormos JM, Pascual-Leone A, and Valls-Sole J. Evoked potentials and quantitative thermal testing in spinal cord injury patients with chronic neuropathic pain. Clin Neurophysiol 2011. DOI: 10.1016/j.clinph.2011.07.038.
24. Kusuda R, Cadetti F, Ravanelli MI, Sousa TA, Zanon S, De Lucca FL, and Lucas G. Differential expression of micro-RNAs in mouse pain models. Mol Pain 7: 17, 2011.
25. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, and Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115: 71-83, 2005.
26. Lin Q, Peng YB, and Willis WD. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition. J Neurophysiol 75: 109-123, 1996. (Pubitemid 26072027)
27. Ma W, Chabot JG, Vercauteren F, and Quirion R. Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats. Neurobiol Aging 31: 1227-1237, 2010.
28. Malcangio M and Bowery NG. GABA and its receptors in the spinal cord. Trends Pharmacol Sci 17: 457-462, 1996. (Pubitemid 27028478)
29. Markou A, Liang Y, and Lianidou E. Review: prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 49: 1591-1603, 2011.
30. Merskey H. Clarifying definition of neuropathic pain. Pain 96: 408-409, 2002.
31. Mukhopadhyay P, Brock G, Appana S, Webb C, Greene RM, and Pisano MM. MicroRNA gene expression signatures in the developing neural tube. Birth Defects Res A Clin Mol Teratol 91: 744-762, 2011.
32. Nakagawa T and Kaneko S. Spinal astrocytes as therapeutic targets for pathological pain. J Phamacol Sci 114: 347-353, 2010.
33. Ossipov MH, Lai J, Malan TP Jr, and Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 909: 12-24, 2000. (Pubitemid 30462030)
34. Raghavendra V, Tanga F, and DeLeo JA. Inhibition of mi-croglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306: 624-630, 2003. (Pubitemid 36886161)
35. Sapadin AN and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54: 258-265, 2006. (Pubitemid 43144395)
36. Schneider M, Andersen DC, Silahtaroglu A, Lyngbæk S, Kauppinen S, Hansen JL, and Sheikh SP. Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochem-istry. J Mol Histol 42: 289-299, 2011.
37. Shin MS, Chung BS, and Kim YS. Effect of cyclosporin a in a rat spinal cord injury model. J Korean Neurosurg Soc 27:1361-1369, 1998.
38. Siddall PJ and Loeser JD. Pain following spinal cord injury. Spinal Cord 39: 63-73, 2001. (Pubitemid 32229131)
39. Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, and Wulczyn FG. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21: 1469-1477, 2005. (Pubitemid 40646593)
40. Vallejo R, Tilley DM, Vogel L, and Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 10: 167-184, 2010.
41. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, and Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260, 2006. (Pubitemid 44871645)
42. Voscopoulos C and Lema M. When does acute pain become chronic? Br J Anaesth 105(Suppl 1): i69-i85, 2010.
43. Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, and Chung JM. Reactive oxygen species contribute to neuropathic painbyreducing spinal GABA release. Pain 152: 844-852, 2011.
44. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96: 13496-13500, 1999.
45. Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC, Oh YJ, Markelonis GJ, and Oh TH. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27: 7751-7761, 2007. (Pubitemid 47093808)
46. Zhao J, Lee MC, Momin A, Cendan CM, Shepherd ST, Baker MD, Asante C, Bee L, Bethry A, Perkins JR, Nassar MA, Abrahamsen B, Dickenson A, Cobb BS, Merkenschlager M, and Wood JN. Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci 30: 10860-10871, 2010.
47. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN,Tsuchihashi T, McManus MT, Schwartz RJ, and Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303-317, 2007. (Pubitemid 46574975)